Mitsui Chemicals AI Stock Analysis
Want to see MITUY full AI Analyst Report?
Mitsui Chemicals (MITUY) AI Stock Analysis
Mitsui Chemicals
(Other OTC:MITUY)
The score reflects a middling but improving fundamental picture offset by poor price momentum, partly cushioned by an inexpensive valuation. Earnings, margins and return on equity are recovering strongly off a weak base and operating cash generation is dependable, but net margins remain thin and volatile, debt now slightly exceeds equity, and free cash flow has contracted as capital spending consumes most operating cash. Technically the stock is in a downtrend, trading below all key moving averages with negative MACD momentum. A low 7.8x P/E and 4.1% dividend yield provide valuation support and income, making this a stabilizing but not compelling overall profile pending confirmation that margin gains and deleveraging can be sustained through the chemical cycle.
Mitsui Chemicals (MITUY) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $3.64B
- Dividend Yield
- 4.68%
- Average Volume (3M)
- 498
- Price to Earnings (P/E)
- 6.7
- Beta (1Y)
- 0.88
- Revenue Growth
- 0.35%
- EPS Growth
- 377.13%
- Country
- US
- Employees
- 16,967
- Sector
- Basic Materials
- Sector Strength
- 61
- Industry
- Chemicals
Mitsui Chemicals Business Overview & Revenue Model
Company Description
Mitsui Chemicals, Inc. is a diversified chemical enterprise operating across key sectors including mobility, healthcare, food and packaging, and basic materials. Within its Mobility division, it develops and supplies elastomers, various performance c...
How the Company Makes Money
Mitsui Chemicals makes money primarily by manufacturing and selling chemical products and materials to business customers (B2B) in Japan and internationally. Its revenue model is product-sales driven, with earnings generated from (1) higher-volume co...
Mitsui Chemicals Earnings Call Summary
The earnings call highlighted growth in the Mobility Solutions segment and strong cash flow improvements, but these were overshadowed by significant declines in overall revenue, particularly in Basic & Green Materials, and continuing challenges in the semiconductor and smartphone markets. The forecast was also downgraded, indicating ongoing difficulties.
Q3-2024 Updates
Positive Updates
Negative Updates
Company Guidance
During the Mitsui Chemicals earnings call for the third quarter of fiscal year 2023, CFO Nakajima provided guidance indicating a challenging period due to sluggish demand in key markets and falling raw material prices, leading to a year-over-year decline in sales and profits. The company revised its full-year forecast for operating income before special items from JPY 112.0 billion to JPY 93.0 billion, and net income was adjusted downward to JPY 50.0 billion, partly due to restructuring losses. Despite these challenges, the annual dividend remains projected at JPY 140 per share. Significant declines in semiconductor and smartphone markets impacted the ICT solutions segment, while the Life & Healthcare segment struggled with inventory adjustments. Mobility Solutions showed resilience with a forecasted operating income increase to JPY 57.0 billion, driven by growth in solar cell materials and automotive recovery. Overall, Mitsui Chemicals anticipates a JPY 20.9 billion decrease in profit for the year, with free cash flows expected to be positive at JPY 24.0 billion.
Mitsui Chemicals Financial Statement Overview
Summary
Mitsui Chemicals is in the early stages of a cyclical earnings recovery. Revenue returned to growth (+6.5% TTM), gross margin expanded from ~20% to ~24%, operating margin nearly doubled to 7.6%, and net income more than doubled to about ¥86 billion, lifting return on equity to ~9.7%. Operating cash flow of ~¥176 billion is roughly twice net income, indicating good cash quality. However, net margin remains thin at ~4.7% and historically volatile, leverage has risen with debt-to-equity above 1.0x (from 0.86x) and equity funding only ~36% of assets, and free cash flow fell ~24% to ~¥41 billion as capital spending absorbs most operating cash. The profile is financially stable rather than strong.
Income Statement
58NeutralBalance Sheet
52NeutralCash Flow
55Neutral| Breakdown | TTM | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.74T | 1.81T | 1.77T | 1.75T | 1.88T | 1.61T |
| Gross Profit | 378.77B | 388.29B | 403.46B | 370.80B | 381.49B | 378.74B |
| EBITDA | 151.44B | 186.12B | 202.22B | 183.24B | 182.81B | 216.99B |
| Net Income | 17.98B | 32.24B | 36.45B | 50.00B | 82.94B | 109.99B |
Balance Sheet | ||||||
| Total Assets | 2.10T | 2.15T | 2.16T | 2.22T | 2.07T | 1.93T |
| Cash, Cash Equivalents and Short-Term Investments | 198.75B | 209.23B | 183.91B | 249.51B | 262.72B | 224.65B |
| Total Debt | 696.42B | 737.98B | 743.40B | 756.76B | 738.25B | 666.09B |
| Total Liabilities | 1.12T | 1.18T | 1.17T | 1.23T | 1.18T | 1.13T |
| Stockholders Equity | 854.37B | 848.28B | 868.48B | 862.85B | 786.83B | 712.65B |
Cash Flow | ||||||
| Free Cash Flow | 84.49B | 62.09B | 89.86B | 7.35B | -36.62B | -23.63B |
| Operating Cash Flow | 212.32B | 200.50B | 225.83B | 161.34B | 101.24B | 92.58B |
| Investing Cash Flow | -153.26B | -165.01B | -145.41B | -123.94B | -106.34B | -205.23B |
| Financing Cash Flow | -33.74B | -74.44B | -78.00B | -26.02B | 2.54B | 89.22B |
Mitsui Chemicals Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MITUY, the sentiment is Negative. The current price of 9.91 is below the 20-day moving average (MA) of 11.69, below the 50-day MA of 12.76, and below the 200-day MA of 13.11, indicating a bearish trend. The MACD of -0.75 indicates Positive momentum. The RSI at 26.77 is Positive, neither overbought nor oversold. The STOCH value of 23.04 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for MITUY.
Mitsui Chemicals Peers Comparison
Overall Rating
CE61Neutral
MITUY56Neutral
DD55Neutral
DOW52Neutral
HUN44Neutral
BAK42Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 61Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
| 61Neutral | $4.94B | 18.91 | 6.35% | 0.27% | 1.43% | ― | |
| 56Neutral | $3.68B | 6.74 | 9.74% | 4.68% | 0.35% | 377.13% | |
| 55Neutral | $19.27B | 64.64 | 2.18% | 1.65% | -43.45% | ― | |
| 52Neutral | $21.01B | -23.04 | -4.50% | 4.82% | 4.16% | 20.86% | |
| 44Neutral | $1.47B | -8.76 | -6.12% | 4.19% | 6.49% | 47.81% | |
| 42Neutral | $386.35M | -0.38 | 45.33% | ― | 8.56% | -31.27% |
* Basic Materials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| MITUY | Mitsui Chemicals (OTC) | 9.91 | -1.95 | -16.43% | |
| CE | Celanese | 45.01 | 6.35 | 16.43% | |
| BAK | Braskem Sa | 0.74 | -2.25 | -75.32% | |
| HUN | Huntsman | 8.36 | -0.21 | -2.42% | |
| DD | DuPont de Nemours, Inc. | 145.43 | 32.02 | 28.23% | |
| DOW | Dow Inc. | 29.03 | 7.56 | 35.21% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 14, 2026
